Last reviewed · How we verify
autologous bone marrow concentrate
Autologous bone marrow concentrate, marketed by Istituto Ortopedico Rizzoli, holds a unique position in the regenerative medicine space. The key composition patent, set to expire in 2028, provides a significant barrier to entry for competitors. However, the lack of clear primary indication and revenue data poses a strategic risk in assessing market potential and financial performance.
At a glance
| Generic name | autologous bone marrow concentrate |
|---|---|
| Sponsor | Istituto Ortopedico Rizzoli |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Arthroscopic Treatment of Acetabular Labral Lesions: Intrarticular Injection of Bone Marrow vs Hip Arthroscopy Alone (NA)
- Acellular Matrix From Human Dermis in Combination With Orthobiologic Stimuli for Augmentation of Massive Rotator Cuff Tears (NA)
- Biologic Injection For Adults With Lumbar Disc Herniation (NA)
- Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis (NA)
- HyaloFAST Trial for Repair of Articular Cartilage in the Knee (NA)
- CAM Procedure With BMAC for Shoulder OA (PHASE1)
- Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction (NA)
- Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- autologous bone marrow concentrate CI brief — competitive landscape report
- autologous bone marrow concentrate updates RSS · CI watch RSS
- Istituto Ortopedico Rizzoli portfolio CI